HAIN
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

The Hain Celestial Group, Inc. is a health and wellness company founded in 1993 that markets and sells products across beverages, yogurt, baby and kids foods, pantry items, and personal care. The company operates through two geographic segments: North America and International. In North America, it sells products in the United States and Canada through supermarkets, natural food stores, mass-market retailers, e-commerce platforms, and food service channels. Key brands in this region include Celestial Seasonings teas, The Greek Gods yogurt, Earth’s Best organic baby foods, Spectrum culinary oils, MaraNatha nut butters, and personal care brands Alba Botanica, Avalon Organics, and JASON. The International segment, which includes operations in the United Kingdom, Ireland, and Europe, features brands such as Ella’s Kitchen baby foods, Joya and Natumi plant-based beverages, Hartley’s jelly, and soups from New Covent Garden, Yorkshire Provender, and Cully & Sully. In 2026, the company completed the sale of its North American Snacks business and entered into an agreement to sell its International business to entities affiliated with AURELIUS.

Summarised from the company's own disclosures, fiscal year ended Sep 2026

Industry Packaged Foods Homepage hain.com
Sector Consumer Defensive IR page ir.hain.com/blog
Tags
organic foods, plant-based beverages, baby food, herbal teas, greek yogurt, personal care, nut butters, culinary oils, soups, jams and jellies, Celestial Seasonings, The Greek Gods, Earth’s Best, Ella’s Kitchen, Joya, Natumi, Hartley’s, Cully & Sully, Yorkshire Provender, New Covent Garden, Spectrum, Spectrum Essentials, MaraNatha, Imagine, Alba Botanica, Avalon Organics, JASON, Live Clean, Robertson’s, Garden Veggie Snacks, Terra, Garden of Eatin’, Farmhouse Fare, Sleepytime, Lemon Zinger, Red Zinger, Bengal Spice, Country Peach Passion, Tea Well
Press page —

Metrics

Valuation  
Market cap $ 44.382M
Market cap (USD) $ 44.382M
P/E -0.15
PEG —
P/BV 0.31
P/S 0.04
P/OCF 0.65
P/FCF -14.01
Dividend yield —
Turnover / mcap —
Returns  
ROE -96.8%
ROI -42.8%
ROIC -21.4%
Profit margin -22.5%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 360.7%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 5
Quality score -58.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 1.353B 1.56B 1.736B 1.797B 1.892B 1.97B 2.054B 2.302B 2.458B 2.853B 2.885B 2.689B 2.154B 1.735B 1.378B 1.13B 917.337M 1.135B 1.056B 900.432M 738.557M 619.967M 544.058M 466.459M 395.954M 412.88M 403.543M
Net profit -304.923M -530.841M -75.042M -116.537M 77.873M 77.364M -80.407M -183.314M 9.694M 67.43M 47.429M 167.896M 139.851M 114.656M 79.225M 54.982M 28.619M -24.723M 41.221M 47.482M 37.067M 21.87M 27.008M 27.492M 2.971M 23.589M -17.097M
Free cash flow — -3.169M 82.894M 38.94M 40.276M — — — — — — — — — — — — 8.635M 4.675M 55.02M — 25.083M 20.883M 12.784M 1.251M 9.367M 6.266M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 0.56 1.52 6.91 12.51 23.74 40.12 31.51 21.9 29.8 38.82 49.75 65.86 88.74 65 55.04 33.34 20.2 15.65 26.33 29.91 26.33 — — — — — —
Price performance 12m -0.63 -0.78 -0.45 -0.47 -0.41 0.27 0.44 -0.27 -0.23 -0.22 -0.24 -0.26 0.37 0.18 0.65 0.65 0.29 -0.41 -0.12 0.14 — — — — — — —

Filed figures

Figure Jun 2017 Jun 2018 Jun 2019 Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024 Jun 2025 Jun 2026
Balance sheet detail
Trade receivables (USD) 248M 253M 237M 171M 174M 171M 161M 179M 154M 121M
↳ YoY growth -10.9% +1.7% -6.2% -27.8% +1.8% -2.0% -5.7% +11.3% -13.8% -21.6%
↳ 5y CAGR +8.3% +1.6% -3.8% -11.8% -9.0% -7.2% -8.6% -5.4% -2.0% -7.0%
Borrowings, current (USD) 9.84M 26.6M 25.9M 1.66M 530,000 7.71M 7.57M 7.57M 7.65M 558M
Borrowings, non-current (USD) 740M 688M 614M 281M 230M 881M 821M 737M 697M 292,000
Lease liabilities (USD) — — 0.00 83M 97.4M 121M 101M 91.8M 80.8M 56.1M
Cash and deposits (USD) 147M 107M 39.5M 37.8M 75.9M 65.5M 53.4M 54.3M 54.4M 58.1M
Intangible assets (USD) 573M 510M 465M 346M 315M 478M 298M 245M 211M 174M
Right-of-use assets (USD) — — 0.00 88.2M 92M 115M 95.9M 86.6M 71.2M 49.1M
Net debt (borrowings + leases - cash) (USD) 603M 608M 600M 328M 253M 944M 876M 782M 731M 556M
Cash flow detail
Operating cash flow (USD) 217M 121M 49.5M 157M 197M 80.2M 66.8M 116M 22.1M 78.3M
Change in receivables (cash effect) (USD) 27.7M -24.8M 21.2M 33.9M -2.89M -5.35M 13.1M -19M 25.2M 35.8M
Change in inventories (cash effect) (USD) -21M -45M 20.6M 33.2M -38.5M -25.3M 189,000 31.5M -3.35M 72.9M
Change in payables (cash effect) (USD) 6.81M 49.3M -17M -31.6M -10.4M -19.9M -40.7M 50.6M -17.9M -6.63M
Share buybacks (cash effect) (USD) — 0.00 0.00 -60.2M -106M -410M 0.00 0.00 — —
Interest paid (cash effect) (USD) -18.9M -24.2M -33.8M -15.5M -5.9M -9.93M -41.7M -52.5M -46.3M -49.9M
Income taxes paid (cash effect) (USD) 2.9M -24.3M -22.5M -16.2M -33M -19.2M -14.8M -10.3M -12.1M -14.7M
Share-based compensation (USD) 9.66M 11.2M 9.93M 13.1M 15.7M 15.6M 14.4M 12.7M 8.15M 5.47M
Operating cash flow before change in receivables (USD) 189M 146M 28.3M 123M 200M 85.6M 53.8M 135M -3.09M 42.5M
Income detail
Research and development expense (USD) 10.1M 9.7M 11.1M 11.7M 10.4M 9.42M 6.38M 5.37M 5.22M 6.17M
↳ 5y CAGR +21.0% +5.2% +2.0% +2.6% -1.8% -1.5% -8.0% -13.6% -14.8% -9.9%
Total comprehensive income (USD) 44.1M 20.9M -224M -26.8M 176M -13.6M -78.3M -86.1M -475M -325M
Comprehensive income to owners (USD) 44.1M 20.9M -224M -26.8M 176M -13.6M -78.3M -86.1M -475M -325M
Provision for credit losses (USD) 91,000 1.69M — — — — — — — —
Credit cost ratio (credit losses / average receivables) (%) 0.0% 0.7% — — — — — — — —
Reported Aug 29, 2018 Aug 25, 2020 Aug 25, 2020 Aug 25, 2020 Aug 25, 2022 Aug 24, 2023 Aug 24, 2023 Aug 27, 2024 Sep 15, 2025 Sep 14, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Final required regulatory approvals received for the sale of the Company’s International business

HOBOKEN, N.J., November 9, 2026 — The Hain Celestial Group, Inc. (Nasdaq: HAIN) ("Hain" or the "Company"), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, today reported financial results for its fiscal first quarter ended September 30, 2026.

"During the first quarter, we made progress on our strategic actions to realign our cost structure, drive productivity, and improve our commercial and innovation capabilities. We saw our gross margin improve meaningfully year over year, reflecting progress on both our commercial and portfolio actions. We remain focused on simplifying our operating model and creating a stronger go-forward Hain,” said Alison Lewis, President and CEO.

The Company also announced that, in early November 2026, the final required regulatory approvals were received for the sale of its International business to global private equity firm AURELIUS, satisfying the regulatory approval condition to closing.

On October 11, 2026, the Board of Directors (the “Board”) of The Hain Celestial Group, Inc. (“Hain Celestial” or the “Company”) appointed Patricia Ferrari and Richard Shinder as new directors, effective immediately. Ms. Ferrari was also appointed as a member of each of the Compensation Committee and Strategy Committee of the Board, and Mr. Shinder was also appointed as a member of each of the Audit Committee and Strategy Committee of the Board, each effective upon their appointment as a director.

Ms. Ferrari has served as an independent director for both public and private companies since 2023. Previously, she was a Managing Director at MBIA Inc. Prior to this, she practiced law for 22 years and served as one of the founding partners of the New York office of King & Spalding. Ms. Ferrari currently serves as an independent director for Panolam Holdings, Outpatient Imaging Affiliates, QualDerm Partners and CityBridge. Ms. Ferrari holds a JD from Vanderbilt University School of Law and earned her undergraduate degree from Southern Illinois University.

Mr. Shinder is a Co-Founder and Partner at Ensis Partners. Mr.

As previously disclosed, on March 24, 2026, The Hain Celestial Group, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Nasdaq Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that its common stock failed to comply with the minimum bid price required for continued listing on The Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1) based upon the bid price of the common stock closing below $1.00 for 30 consecutive business days. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial compliance period of 180 calendar days, or until September 21, 2026 (the “Initial Compliance Date”), to regain compliance with the minimum bid price requirement. Additionally, the Company was eligible for an additional 180-calendar day compliance period to demonstrate compliance with the minimum bid price requirement, subject to meeting certain requirements.

Prompts

The Hain Celestial Group, Inc. (ticker HAIN), listed in United States.

Company History

Date Change Detail
Jun 9, 2000 Renamed HAIN FOOD GROUP INC → HAIN CELESTIAL GROUP INC

ETFs Holding The Hain Celestial Group, Inc.

ETF Weight in ETF Shares Market value As of
MSSM 0.01% 51,049 $ 38.052K Aug 31, 2026
BSVO 0.00% 75,012 $ 10K Nov 18, 2026